Literature DB >> 12207093

Cardiovascular changes in renal failure.

Karin Tyralla1, Kerstin Amann.   

Abstract

In patients with renal failure cardiovascular complications are an important clinical problem and cardiac death is the main cause of death in these patients. It is well documented that cardiac risk is increased by a factor of 20 in uremic patients compared with age- and sex-matched segments of the general population. This finding in patients with renal failure can be at least partially explained by the well-described structural and metabolic abnormalities of the myocardium. The present article focuses on the structural changes in the heart and the vasculature and their potential repercussions for cardiovascular function, in particular their contribution to the high cardiovascular morbidity and mortality in patients with renal failure. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12207093     DOI: 10.1159/000063551

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  6 in total

Review 1.  Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations.

Authors:  Srisakul Chirakarnjanakorn; Sankar D Navaneethan; Gary S Francis; W H Wilson Tang
Journal:  Int J Cardiol       Date:  2017-01-04       Impact factor: 4.164

2.  Interstitial myocardial fibrosis in a captive chimpanzee (Pan troglodytes) population.

Authors:  Michael L Lammey; Gary B Baskin; Andrew P Gigliotti; D Rick Lee; John J Ely; Meg M Sleeper
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

Review 3.  Na+/Ca2+ exchange and Na+/K+-ATPase in the heart.

Authors:  Michael J Shattock; Michela Ottolia; Donald M Bers; Mordecai P Blaustein; Andrii Boguslavskyi; Julie Bossuyt; John H B Bridge; Ye Chen-Izu; Colleen E Clancy; Andrew Edwards; Joshua Goldhaber; Jack Kaplan; Jerry B Lingrel; Davor Pavlovic; Kenneth Philipson; Karin R Sipido; Zi-Jian Xie
Journal:  J Physiol       Date:  2015-03-15       Impact factor: 5.182

4.  Suppression of NLRP3 Inflammasome Activation Ameliorates Chronic Kidney Disease-Induced Cardiac Fibrosis and Diastolic Dysfunction.

Authors:  Antoinette Bugyei-Twum; Armin Abadeh; Kerri Thai; Yanling Zhang; Melissa Mitchell; Golam Kabir; Kim A Connelly
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

5.  Pathological cardiac remodeling occurs early in CKD mice from unilateral urinary obstruction, and is attenuated by Enalapril.

Authors:  Onju Ham; William Jin; Lei Lei; Hui Hui Huang; Kenji Tsuji; Ming Huang; Jason Roh; Anthony Rosenzweig; Hua A Jenny Lu
Journal:  Sci Rep       Date:  2018-10-31       Impact factor: 4.379

6.  Identification and external validation of the hub genes associated with cardiorenal syndrome through time-series and network analyses.

Authors:  Jingjing Liang; Xiaohui Huang; Weiwen Li; Yunzhao Hu
Journal:  Aging (Albany NY)       Date:  2022-02-08       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.